Blood test may shed light on painful fat disorder
NCT ID NCT07651813
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates whether a natural molecule called Maresin-1, which helps reduce inflammation, is linked to lipedema—a chronic condition causing painful fat buildup in women. Researchers will measure Maresin-1 levels in the blood of women with lipedema, women with obesity but no lipedema, and healthy women. The goal is to see if Maresin-1 could serve as a biomarker to better understand or diagnose this poorly understood disorder.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If Maresin-1 levels differ between groups, it could point toward a simple blood test to help diagnose or monitor lipedema.
- What could go wrong
- This is a small observational study, not a treatment trial. It may find no meaningful differences, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIPEDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Buoyancy vs. gravity: which exercise wins for lipedema relief?
- A simple step test could change how lipedema is assessed
- Can ultrasound reveal why lipedema makes walking hard?
- Can a new questionnaire better measure lipedema symptoms in turkish women?
- Ketogenic diet may offer pain relief for women with lipedema
- Shock waves aim to soothe lipedema pain in new trial